SHAB published 23 Jul 2025 · legal date 9 Jul 2025
Capital increase
Not assessed
Paid in cash
Nominal capital
100’000 → 133’112.59
Shares
— → 13’311’259
New shares, % of post-step shares
— (share counts not published)
Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 133'112.59, divisé en 13'311'259 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts.
SHAB published 10 Nov 2025 · legal date 24 Oct 2025
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
133’112.59 → 245’151.29
Shares
13’311’259 → 24’515’129
New shares, % of post-step shares
45.7% (11’203’870 new)
Augmentation ordinaire du capital-actions. Nouveau capital-actions entièrement libéré: CHF 245'151.29, divisé en 24'515'129 actions nominatives de CHF 0.01, avec restrictions quant à la transmissibilité selon statuts.
From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.88 · likely-financing threshold 0.60 · not a calibrated probability